Compare CORAL LAB. with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs BHARAT PARENTALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CORAL LAB. BHARAT PARENTALS CORAL LAB./
BHARAT PARENTALS
 
P/E (TTM) x 9.0 11.5 78.6% View Chart
P/BV x 0.8 1.8 45.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 CORAL LAB.   BHARAT PARENTALS
EQUITY SHARE DATA
    CORAL LAB.
Mar-21
BHARAT PARENTALS
Mar-21
CORAL LAB./
BHARAT PARENTALS
5-Yr Chart
Click to enlarge
High Rs443514 86.2%   
Low Rs95135 70.2%   
Sales per share (Unadj.) Rs270.5357.1 75.7%  
Earnings per share (Unadj.) Rs38.035.5 107.1%  
Cash flow per share (Unadj.) Rs43.546.0 94.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs382.8250.3 152.9%  
Shares outstanding (eoy) m3.575.73 62.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.00.9 109.5%   
Avg P/E ratio x7.19.2 77.5%  
P/CF ratio (eoy) x6.27.1 87.6%  
Price / Book Value ratio x0.71.3 54.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m9621,860 51.7%   
No. of employees `000NANA-   
Total wages/salary Rs m102148 69.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m9662,046 47.2%  
Other income Rs m3887 43.5%   
Total revenues Rs m1,0032,133 47.0%   
Gross profit Rs m161252 63.8%  
Depreciation Rs m2060 32.9%   
Interest Rs m38 37.0%   
Profit before tax Rs m176271 64.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4168 59.6%   
Profit after tax Rs m136203 66.7%  
Gross profit margin %16.712.3 135.2%  
Effective tax rate %23.025.1 91.8%   
Net profit margin %14.09.9 141.4%  
BALANCE SHEET DATA
Current assets Rs m1,1081,480 74.9%   
Current liabilities Rs m278436 63.7%   
Net working cap to sales %86.051.0 168.6%  
Current ratio x4.03.4 117.6%  
Inventory Days Days13588 152.7%  
Debtors Days Days1,4801,210 122.3%  
Net fixed assets Rs m567506 112.0%   
Share capital Rs m3657 62.4%   
"Free" reserves Rs m1,3311,377 96.6%   
Net worth Rs m1,3661,434 95.3%   
Long term debt Rs m086 0.0%   
Total assets Rs m1,6751,987 84.3%  
Interest coverage x63.236.5 173.4%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.61.0 56.0%   
Return on assets %8.310.6 77.8%  
Return on equity %9.914.2 70.0%  
Return on capital %13.118.3 71.4%  
Exports to sales %72.30-   
Imports to sales %2.00-   
Exports (fob) Rs m698NA-   
Imports (cif) Rs m19NA-   
Fx inflow Rs m698534 130.8%   
Fx outflow Rs m31247 12.4%   
Net fx Rs m668287 232.7%   
CASH FLOW
From Operations Rs m11313 3.6%  
From Investments Rs m-2-479 0.4%  
From Financial Activity Rs m383 3.6%  
Net Cashflow Rs m12-84 -14.4%  

Share Holding

Indian Promoters % 32.3 74.4 43.4%  
Foreign collaborators % 39.2 0.0 -  
Indian inst/Mut Fund % 0.4 0.0 4,200.0%  
FIIs % 0.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.5 25.6 111.4%  
Shareholders   4,425 2,805 157.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CORAL LAB. With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CORAL LAB. SHARE PRICE


Jan 25, 2022 (Close)

TRACK CORAL LAB.

  • Track your investment in CORAL LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE CORAL LAB. WITH

MARKET STATS